Growth Metrics

DBV Technologies (DBVT) Operating Expenses (2014 - 2026)

DBV Technologies (DBVT) reported Operating Expenses of $48.8 million for Q1 2026, up 78.1% year-over-year from $27.4 million in Q1 2025, and up 6.8% on a QoQ basis from $45.7 million in Q4 2025.

DBV Technologies (DBVT) has 12 years of Operating Expenses data on file, last reported at $48.8 million in Q1 2026.

  • Quarterly Operating Expenses rose 78.1% year-over-year to $48.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174.1 million (up 47.34% YoY) and the FY2025 annual result came in at $152.7 million, up 26.46% from the prior year.
  • Operating Expenses rose to $48.8 million in Q1 2026 per DBVT's latest filing, from $45.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $48.8 million in Q1 2026 and bottomed at $19.3 million in Q1 2022.
  • The 5-year median for Operating Expenses is $27.4 million (2025), against an average of $30.3 million.
  • The widest annual swing landed in 2022, when Operating Expenses jumped 123.71%; it then tumbled 43.36% in 2023.
  • Tracing DBVT's Operating Expenses over 5 years: stood at $36.7 million in 2022, then plunged by 43.36% to $20.8 million in 2023, then gained by 17.2% to $24.4 million in 2024, then jumped by 87.49% to $45.7 million in 2025, then gained by 6.8% to $48.8 million in 2026.
  • Per Business Quant, the three latest DBVT Operating Expenses figures stand at $48.8 million (Q1 2026), $45.7 million (Q4 2025), and $37.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.97 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.33 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -138.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 15.76 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.85 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 898.54 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 48.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 48.80 Mn
Dec 31, 2025 45.70 Mn
Sep 30, 2025 37.05 Mn
Jun 30, 2025 42.58 Mn
Mar 31, 2025 27.40 Mn
Dec 31, 2024 24.37 Mn
Sep 30, 2024 31.40 Mn
Jun 30, 2024 35.00 Mn
Mar 31, 2024 29.96 Mn
Dec 31, 2023 20.80 Mn
Sep 30, 2023 20.64 Mn
Jun 30, 2023 27.36 Mn
Mar 31, 2023 23.36 Mn
Dec 31, 2022 36.71 Mn
Sep 30, 2022 20.09 Mn
Jun 30, 2022 25.35 Mn
Mar 31, 2022 19.32 Mn
Dec 31, 2021 16.41 Mn
Sep 30, 2021 25.69 Mn
Jun 30, 2021 29.65 Mn
Mar 31, 2021 32.58 Mn
Dec 31, 2020 38.95 Mn
Sep 30, 2020 33.92 Mn
Jun 30, 2020 51.31 Mn
Mar 31, 2020 45.94 Mn
Sep 30, 2019 -38.23 Mn
Dec 31, 2018 -60.48 Mn
Sep 30, 2018 -54.60 Mn
Jun 30, 2016 -61.16 Mn
Dec 31, 2015 -6.02 Mn
Jun 30, 2015 -19.99 Mn
Dec 31, 2014 -5.22 Mn
Jun 30, 2014 -20.22 Mn